Vs. Spiegelman et al., RESISTANCE OF TRANSFORMED MOUSE KERATINOCYTES TO GROWTH-INHIBITION BYGLUCOCORTICOIDS, Molecular carcinogenesis, 20(1), 1997, pp. 99-107
Glucocorticoid hormones are strong inhibitors of normal keratinocyte p
roliferation, but established mouse skin papillomas and carcinomas bec
ome resistant to these hormones. The biological effect of glucocortico
ids is mediated through a highly specific glucocorticoid receptor (GR)
. To study the possible mechanisms of glucocorticoid resistance of tra
nsformed mouse keratinocytes, we evaluated GR expression and function
in non-tumorigenic (3PC), papilloma-producing (MT1/2 and P1/17), and s
quamous cell carcinoma-producing (Ca3/7 and Ca8/29) keratinocyte cell
lines and analyzed the DNA sequence of GR in glucocorticoid-sensitive
and glucocorticoid-resistant keratinocytes. All transformed keratinocy
te cell lines studied appeared to be completely resistant to the growt
h inhibition by the glucocorticoid fluocinolone acetonide (FA), wherea
s the untransformed cell line 3PC was very sensitive to FA. Despite th
e glucocorticoid resistance, all the tumorigenic keratinocyte cell lin
es expressed high levels of GR mRNA and protein. Southern blot analysi
s and direct sequencing of the DNA-binding domain of the GR gene revea
led no significant changes in GR gene structure in transformed keratin
ocytes. To test the functional capability of GR, we compared the effec
t of FA on the expression of glucocorticoid-responsive genes. FA stron
gly induced metallothionein 1 expression in 3PC cells, slightly induce
d metallothionein 1 expression in P1/17 and Ca3/7 cells, and did not a
ffect its expression in MT1/2 and Ca8/29 cells. These data suggest tha
t resistance to the growth inhibition of glucocorticoids is an importa
nt feature of tumorigenic keratinocyte cell lines. It is likely that t
his hormone-resistant phenotype is a result of alteration of GR functi
on but not of GR expression or gene structure. (C) 1997 Wiley-Liss, In
c.